Stay updated with breaking news from Johan Gil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
May 31, 2023 - InDex Pharmaceuticals Holding AB today announced that a license agreement has been signed with Viatris Pharmaceutical Japan Inc. to register and commercialize cobitolimod in Japan... | June 7, 2023
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) invites investors, analysts and media to attend a live business update during which Jenny Sundqvist,...
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced positive results from a pharmacokinetic (PK) study with cobitolimod in patients with...
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the company will attend the annual congress of the European Crohn's and Colitis...
STOCKHOLM, Feb. 14, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) is today making a presentation with CEO Jenny Sundqvist available in light of the press release issued January